Paper29655451
Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.
Rivner MH and 4 others. Neurol Clin, 2018. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies. Papers, record 29655451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29655451
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Autoantibodies | Major topic |
| Autoantigens | Major topic |
| Myasthenia Gravis | Major topic |
| Receptor Protein-Tyrosine Kinases | Major topic |
| Receptors, Cholinergic | Major topic |
| Humans | |
| Neuromuscular Junction | |
| Phenotype |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AG051510 | NIA NIH HHS | United States | R01AG051510 | PubMed and NIH | NIH RePORTER |
| R01 NS090083 | NINDS NIH HHS | United States | R01NS090083 | PubMed and NIH | NIH RePORTER |
References162
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7675108 | Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice. | Nature | 1995 | https://conductscience.org/library/papers/7675108 | PubMed |
| 2 | 6652683 | Crosslinking of proteins in acetylcholine receptor-rich membranes: association between the beta-subunit and the 43 kd subsynaptic protein. | Cell | 1983 | https://conductscience.org/library/papers/6652683 | PubMed |
| 3 | 12929188 | Rapsyn mutations in myasthenic syndrome due to impaired receptor clustering. | Muscle Nerve | 2003 | https://conductscience.org/library/papers/12929188 | PubMed |
| 4 | 3170600 | Identification of the mouse muscle 43,000-dalton acetylcholine receptor-associated protein (RAPsyn) by cDNA cloning. | J Biol Chem | 1988 | https://conductscience.org/library/papers/3170600 | PubMed |
| 5 | 21565192 | Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice. | Exp Neurol | 2011 | https://conductscience.org/library/papers/21565192 | PubMed |
| 6 | 24504626 | Treatment of MuSK-Associated Myasthenia Gravis. | Curr Treat Options Neurol | 2014 | https://conductscience.org/library/papers/24504626 | PubMed |
| 7 | 19548060 | Juvenile seropositive myasthenia gravis with anti-MuSK antibody after thymectomy. | J Neurol | 2009 | https://conductscience.org/library/papers/19548060 | PubMed |
| 8 | 17157556 | Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies. | Clin Neurophysiol | 2007 | https://conductscience.org/library/papers/17157556 | PubMed |
| 9 | 24825477 | Electrophysiological profile of the patients with MuSK positive myasthenia gravis. | Neurol Res | 2014 | https://conductscience.org/library/papers/24825477 | PubMed |
| 10 | 18378885 | A transient neonatal myasthenic syndrome with anti-musk antibodies. | Neurology | 2008 | https://conductscience.org/library/papers/18378885 | PubMed |
| 11 | 17709714 | Anti-musk antibody after thymectomy in a previously seropositive myasthenic child. | Neurology | 2007 | https://conductscience.org/library/papers/17709714 | PubMed |
| 12 | 7546737 | Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscle, at the neuromuscular junction, and after injury. | Neuron | 1995 | https://conductscience.org/library/papers/7546737 | PubMed |
| 13 | 27170368 | Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis. | Curr Neurol Neurosci Rep | 2016 | https://conductscience.org/library/papers/27170368 | PubMed |
| 14 | 24297891 | MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/24297891 | PubMed |
| 15 | 21890498 | A valid mouse model of AGRIN-associated congenital myasthenic syndrome. | Hum Mol Genet | 2011 | https://conductscience.org/library/papers/21890498 | PubMed |
| 16 | 23322599 | Double-seropositive myasthenia gravis. | Muscle Nerve | 2013 | https://conductscience.org/library/papers/23322599 | PubMed |
| 17 | 11231638 | Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. | Nat Med | 2001 | https://conductscience.org/library/papers/11231638 | PubMed |
| 18 | 19063688 | A comparison of long-term post-thymectomy outcome of anti-AChR-positive, anti-AChR-negative and anti-MuSK-positive patients with non-thymomatous myasthenia gravis. | Expert Opin Biol Ther | 2009 | https://conductscience.org/library/papers/19063688 | PubMed |
| 19 | 17533129 | Musk-antibody positive myasthenia gravis presenting with isolated neck extensor weakness. | Neuromuscul Disord | 2007 | https://conductscience.org/library/papers/17533129 | PubMed |
| 20 | 17212617 | Anti-MuSK-positive myasthenia gravis: neuromuscular transmission failure in facial and limb muscles. | Acta Neurol Scand | 2007 | https://conductscience.org/library/papers/17212617 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40584517 | Consensus guidelines on the diagnosis and management of myasthenia gravis by the Saudi Arabia Neuromuscular and Electrodiagnostic Medicine and neuromuscular specialists from the Gulf Cooperation Council region. | Ther Adv Neurol Disord | 2025 | https://conductscience.org/library/papers/40584517 | PubMed |
| 40304847 | High-Dose Steroids, Treatment Escalation, and Healthcare Burden in Myasthenia Gravis: A US Claims-Based Cohort Study. | Neurol Ther | 2025 | https://conductscience.org/library/papers/40304847 | PubMed |
| 39387949 | Treatment of myasthenia gravis in france: A retrospective claims database study (STAMINA). | J Neurol | 2024 | https://conductscience.org/library/papers/39387949 | PubMed |
| 39006634 | Rituximab Therapy for Immune-Mediated Neurological Diseases: Our Experience at a Tertiary Care Centre. | Cureus | 2024 | https://conductscience.org/library/papers/39006634 | PubMed |
| 38785143 | Astragaloside IV protects against autoimmune myasthenia gravis in rats via regulation of mitophagy and apoptosis. | Mol Med Rep | 2024 | https://conductscience.org/library/papers/38785143 | PubMed |
| 38748320 | Myasthenia Gravis Disease Burden and Its Impact on Satisfaction with Life: A Qualitative Survey of Patients' Perspectives in Japan. | Neurol Ther | 2024 | https://conductscience.org/library/papers/38748320 | PubMed |
| 36815443 | The role of Rapsyn in neuromuscular junction and congenital myasthenic syndrome. | Biomol Biomed | 2023 | https://conductscience.org/library/papers/36815443 | PubMed |
| 35246057 | Spotlight on MuSK positive myasthenia gravis: clinical characteristics, treatment and outcomes. | BMC Neurol | 2022 | https://conductscience.org/library/papers/35246057 | PubMed |
| 34829445 | Comparative Analysis of BIOCHIP Mosaic-Based Indirect Immunofluorescence with Enzyme-Linked Immunosorbent Assay for Diagnosing Myasthenia Gravis. | Diagnostics (Basel) | 2021 | https://conductscience.org/library/papers/34829445 | PubMed |
| 34599742 | The Role of Plasma Exchange in the Treatment of Refractory Autoimmune Neurological Diseases: a Narrative Review. | J Neuroimmune Pharmacol | 2021 | https://conductscience.org/library/papers/34599742 | PubMed |
| 34143342 | Disease severity and response to treatment in Iranian patients with myasthenia gravis. | Neurol Sci | 2022 | https://conductscience.org/library/papers/34143342 | PubMed |
| 34007311 | The mitochondrial biogenesis signaling pathway is a potential therapeutic target for myasthenia gravis via energy metabolism (Review). | Exp Ther Med | 2021 | https://conductscience.org/library/papers/34007311 | PubMed |
| 33629204 | Giant cell myositis associated with concurrent myasthenia gravis: a case-based review of the literature. | Clin Rheumatol | 2021 | https://conductscience.org/library/papers/33629204 | PubMed |
| 33329368 | Controversies in Ocular Myasthenia Gravis. | Front Neurol | 2020 | https://conductscience.org/library/papers/33329368 | PubMed |
| 32859770 | Possible implications of dysregulated nicotinic acetylcholine receptor diffusion and nanocluster formation in myasthenia gravis. | Neural Regen Res | 2021 | https://conductscience.org/library/papers/32859770 | PubMed |
| 32547365 | Myasthenia Gravis: From the Viewpoint of Pathogenicity Focusing on Acetylcholine Receptor Clustering, Trans-Synaptic Homeostasis and Synaptic Stability. | Front Mol Neurosci | 2020 | https://conductscience.org/library/papers/32547365 | PubMed |
| 32444555 | Retrospective Analysis of Eculizumab in Patients with Acetylcholine Receptor Antibody-Negative Myasthenia Gravis: A Case Series. | J Neuromuscul Dis | 2020 | https://conductscience.org/library/papers/32444555 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29655451
GET https://conductscience.org/api/papers/v1/29655451/references?page=2